This site is intended for Healthcare professionals only.
Elsevier-Clinicalkey

U.S. FDA approves Roche bleeding disorder drug


U.S. FDA approves Roche bleeding disorder drug

New Delhi: Roche has recently received approval from U.S. regulators for its haemophilia A drug Hemlibra for use in nearly all patients, as the Swiss drugmaker pushes deeper into diseases beyond cancer to replace revenue from older, patent-expired drugs.

Hemlibra was first approved in November for adults and children with haemophilia A with factor VIII inhibitors.

The injectable medicine that helps blood to clot in patients with the genetic disorder had previously been approved in the United States and Europe for those who had developed resistance, called inhibitors, to older treatments.

Read Also: With new blood test, Roche dives deeper into personal cancer care



Source: self
0 comment(s) on U.S. FDA approves Roche bleeding disorder drug

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted